We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Assessment of Microplastic Exposure in Diabetic Patients Using Insulin
Summary
Researchers compared microplastic levels in blood samples from 50 insulin-dependent diabetic patients and 50 healthy controls. The study found that diabetic patients had significantly higher serum microplastic levels than healthy individuals, and that patients receiving more frequent insulin injections had higher concentrations, suggesting a possible association between insulin delivery methods and microplastic exposure.
This study investigates the potential role of microplastics in the development of diabetes mellitus and assesses their presence in individuals undergoing insulin therapy. A total of 100 participants were included: 50 insulin-dependent diabetic patients and 50 healthy controls. The diabetic group was divided into two subgroups based on their insulin regimen: those receiving one daily injection of basal insulin and those receiving four injections of basal and short-acting insulin. Blood samples were analysed for microplastic content using chromatographic methods (LC/GC-MSMS and LCTOF MS). The findings revealed that diabetic patients had significantly higher serum microplastic levels (3.14 ± 1.30 µg/mL) than healthy individuals (1.50 ± 0.89 µg/mL, p < 0.05). Within the diabetic group, patients receiving four injections had a longer disease duration (15.14 ± 3.64 years) than those receiving one injection (10.56 ± 5.21 years), with a statistically significant difference (p = 0.001). However, microplastic levels did not differ significantly based on injection frequency. A strong positive correlation was observed between microplastic levels and both HbA1c (%) and fasting glucose levels (p = 0.001). These results imply that microplastics may act as endocrine disruptors that contribute to the development of diabetes, rather than being introduced through insulin treatment itself.
Sign in to start a discussion.
More Papers Like This
Exploring the micro- and nanoplastics–diabetes nexus: Shattered barriers, toxic links, and methodological horizons
This review examines growing evidence that micro- and nanoplastics may contribute to diabetes by disrupting blood sugar regulation, insulin signaling, and fat metabolism through oxidative stress and inflammation. Animal studies show that plastic particles can damage the pancreas, liver, and gut in ways that mirror the development of diabetes, though human studies are still limited. The review calls for more research into whether everyday microplastic exposure could be a hidden factor in the global rise of metabolic diseases.
A mixture analysis of urinary microplastic levels and risk of gestational diabetes
A study of pregnant women found novel evidence that urinary microplastic levels were associated with impaired glucose regulation, suggesting that microplastic exposure may contribute to the risk of gestational diabetes.
Characteristics and influencing factors of microplastics entering human blood through intravenous injection
This study found that common medical devices used for intravenous injections -- syringes, infusion sets, and vein needles -- release microplastics directly into patients' bloodstreams. The dominant particles were polyethylene and polypropylene fragments, and repeated use of devices significantly increased the amount released. While the total number of particles entering the body this way is lower than from food, the direct injection into blood makes this exposure pathway especially concerning.
Elevated blood microplastics and their potential association with Parkinson’s disease
Researchers collected blood samples from 21 Parkinson's disease patients and 12 healthy controls and found that patients with Parkinson's had significantly higher levels of microplastics in their blood. The Parkinson's patients also reported more frequent use of disposable plastic products and bottled water, suggesting greater environmental exposure. The study provides early evidence of a potential association between blood microplastic levels and Parkinson's disease, though further research is needed to understand any causal relationship.
Microplastic injection? Identification and quantification of plastic particles in medical injections
Scientists discovered that medical injection solutions (saline and glucose) sold in China contain an average of 895 microplastic particles per kilogram, with some samples reaching 1,840 particles. Unlike microplastics ingested through food, these particles enter the bloodstream directly through IV injection, bypassing the body's digestive barriers. This reveals a previously unrecognized pathway for microplastic exposure that could pose unique health risks for hospitalized patients.